NCT00134173
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Fresno, California, United States